THE EFFECT OF IMPAIRED RENAL-FUNCTION ON THE PLASMA-CONCENTRATION AND URINARY-EXCRETION OF METOPROLOL METABOLITES

被引：49

作者：

HOFFMANN, KJ

REGARDH, CG

AURELL, M

ERVIK, M

JORDO, L

机构：

[1] AB HASSLE,DEPT PHARMACEUT,RES LABS,S-43120 MOLNDAL 1,SWEDEN

[2] SAHLGRENS HOSP,DEPT MED 1,S-41345 GOTHENBURG,SWEDEN

[3] SAHLGRENS HOSP,DEPT MED 2,S-41345 GOTHENBURG,SWEDEN

来源：

CLINICAL PHARMACOKINETICS | 1980年 / 5卷 / 02期

关键词：

D O I：

10.2165/00003088-198005020-00005

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：181 / 191

页数：11

共 22 条

[1] COMBINED PHARMACOKINETIC AND PHARMACODYNAMIC STUDIES ON ALPRENOLOL AND 4-HYDROXY-ALPRENOLOL IN MAN [J].

ABLAD, B ;

BORG, KO ;

JOHNSSON, G ;

REGARDH, CG ;

SOLVELL, L .

LIFE SCIENCES, 1974, 14 (04) :693-704

[2] METABOLISM OF METOPROLOL IN RAT INVITRO AND INVIVO [J].

ARFWIDSSON, A ;

BORG, KO ;

HOFFMANN, KJ ;

SKANBERG, I .

XENOBIOTICA, 1976, 6 (11) :691-711

[3] GUIDELINES FOR DRUG-THERAPY IN RENAL-FAILURE [J].

BENNETT, WM ;

SINGER, I ;

GOLPER, T ;

FEIG, P ;

COGGINS, CJ .

ANNALS OF INTERNAL MEDICINE, 1977, 86 (06) :754-783

[4]

BORG KO, 1975, ACTA PHARMACOL TOX, V36, P125

[5]

DETTLI L, 1970, POSTGRAD MED J, V46, P32

[6] PHARMACOLOGICALLY ACTIVE DRUG METABOLITES - THERAPEUTIC AND TOXIC ACTIVITIES, PLASMA AND URINE DATA IN MAN, ACCUMULATION IN RENAL-FAILURE [J].

DRAYER, DE .

CLINICAL PHARMACOKINETICS, 1976, 1 (06) :426-443

[7] INTERRELATIONSHIP BETWEEN RENAL HEMODYNAMICS, DRUG KINETICS AND DRUG ACTION [J].

DUCHIN, KL ;

SCHRIER, RW .

CLINICAL PHARMACOKINETICS, 1978, 3 (01) :58-71

[8]

ERVIK M, 1975, ACTA PHARMACOL TOX, V36, P136

[9]

ERVIK M, BIOMEDICAL MASS SPEC

[10]

FABRE J, 1976, Clinical Pharmacokinetics, V1, P99, DOI 10.2165/00003088-197601020-00002

← 1 2 3 →